Skip to content

Long-term Safety of UAS-assisted vs Sheathless RIRS in Non-prestented Patients

Long-Term Safety Outcomes of Ureteral Access Sheath-Assisted Versus Sheathless Retrograde Intrarenal Surgery for Renal Stones ≤20 mm in Non-Prestented Patients: A Retrospective Comparative Cohort Study With Active Follow-up

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07767773
Enrollment
1200
Registered
2026-08-17
Start date
2026-08-16
Completion date
2027-12-25
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydronephrosis, Renal Stone Disease, Retrograde Intrarenal Surgery, Ureteral Access Sheath, Ureteral Stricture, Urolithiasis

Brief summary

This retrospective comparative cohort study will include adult patients who underwent primary RIRS for renal stones ≤20 mm at Al-Azhar University Hospitals between January 2020 and December 2025. Patients will be classified by whether a ureteral access sheath (UAS) was used during the index RIRS, and all eligible patients will be invited for active long-term follow-up (minimum 12 months) to assess the composite outcome of delayed ipsilateral ureteral stricture or new/progressive ipsilateral hydronephrosis and other safety and efficacy outcomes. Propensity-score methods and adjusted regression analyses will be used to control confounding.

Detailed description

This retrospective comparative cohort study will evaluate long-term safety outcomes of ureteral access sheath-assisted versus sheathless retrograde intrarenal surgery (RIRS) in adult patients with renal stones measuring ≤20 mm who were not prestented before the index procedure. Eligible patients treated at Al-Azhar University Hospitals between January 2020 and December 2025 will be identified from operative and medical records and then invited for active long-term follow-up. Participants will be categorized according to whether a ureteral access sheath was used during the initial RIRS. The primary outcome is the composite occurrence of delayed ipsilateral ureteral stricture or new/progressive ipsilateral hydronephrosis at least 12 months after surgery. Secondary outcomes include intraoperative ureteral injury, postoperative complications, stone-free rate, renal function, emergency visits, readmissions, and need for additional intervention. Propensity score methods and multivariable analyses will be used to reduce confounding due to nonrandom treatment allocation.

Interventions

PROCEDUREUreteral access sheath-assisted RIRS

Retrograde intrarenal surgery (RIRS) performed with placement of a ureteral access sheath during the initial procedure. Details recorded: sheath diameter (Fr), length, manufacturer/model, insertion success, number of insertion attempts, need for ureteral dilation, intraoperative findings.

PROCEDURESheathless RIRS

RIRS performed without placement of a ureteral access sheath. Details recorded: guidewire use, ureteral dilation, access difficulty, intraoperative findings.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years at time of index RIRS. * Primary RIRS performed at Al-Azhar University Hospitals between Jan 1, 2020 and Dec 31, 2025. * Renal stone(s) with maximum diameter ≤20 mm on preoperative imaging. * No ipsilateral ureteral stent or nephrostomy before index RIRS. * Documented operative record specifying whether a UAS was used. * At least 12 months elapsed since index RIRS. * Available contact information allowing invitation for active follow-up.

Exclusion criteria

* Primary ureteral stone treated during the same procedure. * Staghorn or \>20 mm stone burden. * Prior ipsilateral ureteral stricture or reconstructive surgery. * Congenital renal/ureteral anomalies affecting outcome (e.g., horseshoe kidney, duplicated system). * Incomplete operative or preoperative imaging records that preclude determination of eligibility or exposure (UAS use). * Additional ipsilateral ureteral procedure during follow-up that independently causes ureteral narrowing. * Refusal to participate in active follow-up or failure to attend after repeated attempts.

Design outcomes

Primary

MeasureTime frameDescription
Composite outcome: delayed ipsilateral ureteral stricture or new/progressive ipsilateral hydronephrosis.At least 12 months after the index RIRS procedureIncidence of the composite primary outcome consisting of either delayed ipsilateral ureteral stricture or new/progressive ipsilateral hydronephrosis after retrograde intrarenal surgery (RIRS). Delayed ureteral stricture will be defined by imaging or functional evidence of treated-ureter narrowing, including CT urography, retrograde pyelography, diagnostic ureteroscopy, diuretic renography, persistent/progressive upper-tract obstruction, or need for therapeutic intervention such as ureteral stenting, balloon dilation, endoureterotomy, or reconstructive surgery. New/progressive hydronephrosis will be defined as hydronephrosis absent preoperatively or increased in severity after RIRS, not explained by residual or recurrent stone disease or another non-study cause.

Secondary

MeasureTime frameDescription
Intraoperative ureteral injuryDuring the index RIRS procedureIncidence and severity of ureteral injury during the index RIRS procedure, documented from operative records. Injury will be recorded according to the surgeon's description and, when available, the Traxer and Thomas classification.
Stone-free rate4 to 12 weeks after the index RIRS procedureProportion of patients with complete stone clearance on postoperative imaging, with residual fragments categorized according to the predefined imaging threshold used in the study.
Postoperative infectious complicationsFrom surgery to 30 days after surgery, and during long-term follow-up up to 12 monthsIncidence of postoperative urinary tract infection, fever, or sepsis documented during follow-up after the index RIRS procedure.
Change in serum creatinineBaseline and 12 months after the index RIRS procedureChange in serum creatinine from baseline to 12 months after the index RIRS procedure.
Change in estimated glomerular filtration rateBaseline and 12 months after the index RIRS procedureChange in estimated glomerular filtration rate, calculated using the prespecified creatinine-based equation, from baseline to 12 months after the index RIRS procedure.
Additional stone-related proceduresFrom surgery to 12 months after the index RIRS procedureIncidence of auxiliary procedures, retreatment, or other additional stone-related interventions performed after the index RIRS procedure.

Countries

Egypt

Contacts

CONTACTAbul-fotouh Ahmed
abulfotouhahmed@yahoo.com+201001066756
PRINCIPAL_INVESTIGATORAbul-fotouh Ahmed

Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026